IRIS
PUCCETTI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.933
EU - Europa 6.895
AS - Asia 3.364
SA - Sud America 558
AF - Africa 41
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 18.805
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.831
RU - Federazione Russa 1.489
GB - Regno Unito 1.474
CN - Cina 1.399
SG - Singapore 1.089
IE - Irlanda 960
IT - Italia 761
UA - Ucraina 587
SE - Svezia 566
BR - Brasile 489
FR - Francia 365
DE - Germania 319
HK - Hong Kong 273
KR - Corea 226
FI - Finlandia 190
VN - Vietnam 109
IN - India 68
CA - Canada 62
TR - Turchia 39
NL - Olanda 29
JP - Giappone 28
MX - Messico 25
BE - Belgio 23
PL - Polonia 22
BD - Bangladesh 21
ES - Italia 20
ZA - Sudafrica 19
AT - Austria 17
CZ - Repubblica Ceca 16
AR - Argentina 14
IQ - Iraq 14
ID - Indonesia 12
EC - Ecuador 10
SA - Arabia Saudita 10
MA - Marocco 9
MY - Malesia 9
UZ - Uzbekistan 9
PK - Pakistan 8
VE - Venezuela 8
AU - Australia 7
BO - Bolivia 7
CO - Colombia 7
LT - Lituania 7
CH - Svizzera 6
CL - Cile 6
PE - Perù 6
PY - Paraguay 6
RO - Romania 6
AL - Albania 5
EU - Europa 5
KG - Kirghizistan 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
DO - Repubblica Dominicana 4
IL - Israele 4
IR - Iran 4
KE - Kenya 4
KZ - Kazakistan 4
PH - Filippine 4
UY - Uruguay 4
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
HR - Croazia 3
JM - Giamaica 3
JO - Giordania 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
AZ - Azerbaigian 2
BG - Bulgaria 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
IM - Isola di Man 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MT - Malta 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
GI - Gibilterra 1
GY - Guiana 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
Totale 18.799
Salva come PNG Salva come JPEG
Città #
Southend 1.305
Dallas 1.217
Dublin 959
Fairfield 842
Singapore 667
Ashburn 534
Chandler 469
Jacksonville 461
Santa Clara 428
Woodbridge 395
Moscow 375
Wilmington 344
Beijing 340
Houston 323
Seattle 309
Hong Kong 273
Cambridge 248
Hefei 245
Seoul 224
Ann Arbor 223
Princeton 191
Nanjing 176
New York 154
Siena 129
Los Angeles 93
San Mateo 77
Milan 76
Shanghai 68
Helsinki 66
Buffalo 64
Munich 64
Boardman 61
San Diego 58
Florence 49
São Paulo 47
The Dalles 47
Nanchang 41
Hebei 37
Bengaluru 35
Changsha 34
Ho Chi Minh City 33
Menlo Park 31
Turku 30
Hanoi 29
Columbus 28
Rome 27
Lancaster 26
Shenyang 26
Toronto 26
Jiaxing 25
Tokyo 25
Dearborn 24
London 23
San Francisco 23
Chicago 22
Tianjin 22
Brussels 21
Council Bluffs 20
Hangzhou 17
Kunming 17
Nuremberg 17
Düsseldorf 16
Brooklyn 15
Rio de Janeiro 15
Warsaw 15
Jinan 14
Denver 13
Málaga 13
Ningbo 13
Brno 12
Johannesburg 12
Norwalk 12
Belo Horizonte 11
Boston 11
Brasília 11
Grosseto 11
Izmir 11
Montreal 11
Philadelphia 11
Redondo Beach 11
Stockholm 11
Vienna 11
Guangzhou 10
Taizhou 10
Washington 10
Torino 9
Curitiba 8
Dong Ket 8
Edinburgh 8
Istanbul 8
Paris 8
Phoenix 8
Redwood City 8
Tashkent 8
Cecina 7
Chennai 7
Jakarta 7
Mexico City 7
Naples 7
Pisa 7
Totale 12.665
Salva come PNG Salva come JPEG
Nome #
Potenziale endogeno di trombina (ETP) e parametri di screening della coagulazione. Comparazione tra INR, D-Dimero ed ETP in una popolazione di soggetti anticoagulati con Warfarin per fibrillazione atriale cronica. 353
Endogenous thrombin potential and screening parameters of coagulation [Potenziale endogeno di trombina e parametri di screening della coagulazione] 342
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 341
Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendan 288
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 286
Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome 282
Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status? 270
Residual peripheral blood CD26+leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission 268
Quantitative evaluation of microvessels in Behcet's disease 261
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients 257
Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function. 257
Atherothrombotic risk assessment during tyrosine kinase inhibitors treatment in chronic myeloid leukemia patients: new insight? 248
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 247
Cytokines in acute coronary syndromes 240
Takayasu's arteritis: case report of a patient with recurrent subclavian steal syndrome 237
Effect of two single oral doses of mesoglycan on the coagulative and fibrinolytic system in human. A pharmacodynamic study [Azione di due dosi orali singole di mesoglicano sul sistema coagulativo-fibrinolitico dell'uomo. Studio farmacodinamico] 226
Cardiac dysautonomia and arterial distensibility in essential hypertensives 224
Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study 223
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may explain increased atherothrombotic risk during TKI treatment in chronic myeloid leukemia patients 221
Heart failure and chronic kidney disease in a registry of internal medicine wards 220
Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients 217
Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure 210
Analisi morfometrica ultrastrutturale di piastrine e leucociti nel paziente sottoposto ad angioplastica coronarica e nell'arteriopatia obliterante periferica 209
Coagulative, fibrinolytic and metabolic pattern in patients with central retinal vein occlusion 207
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma 203
Cardiac papillary fibroelastoma: An unusual source of cerebral embolism solved with local fibrinolysis 201
Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects 199
A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid? 199
Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure 198
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010 196
Long-Term use of ticagrelor in patients with prior myocardial infarction 196
Definizione di pattern videocapillaroscopici (VCS) di normalità nel microcircolo cutaneo. Stratificazione secondo l'età 192
Chronic urticaria and blastocystis hominis infection. A case report 190
Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment 190
L’apoptosi linfocitaria nell’infarto miocardico acuto senza sopraelevazione del tratto ST 190
Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study 187
Potenziale endogeno di trombina e parametri di screening della coagulazione. 185
Different mechanisms of fibrinolysis impairment among dyslipidemic subjects 184
Cranial osteolytic metastases as the only recurrence of gastric carcinoma 184
Genetic modulation of anti-inflammatory effects of atorvastatin; probably a multi-gene condition 183
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 179
Circadian rhythm during unfractioned heparin i.v.infusion in man: modification by ASA or pentoxifylline per os 177
Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects 177
Bosentan treatment on Raynaud Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and with Pulmonary Arterial Hypertension: an open-label, observational, retrospective study 174
Plasma brain natriuretic peptide levels in coronary heart disease with preserved systolic function 173
Platelet hyperactivity after statin treatment discontinuation 173
Dyslipidemias and fibrinolysis. 173
Protective effects of novel metal-nonoates on the cellular components of the vascular system 171
In-hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study 169
Complement activation in hypercholesterolemia 168
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 168
Diurnal rhythm of the anticoagulant effect of continuous i.v. infusion of unfractioned heparin: a possible role for platelet activation 168
Pharmacogenetics of statins therapy 167
Central Retinal Vein Occlusion and Prothrombotic Factors 167
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 166
Different effect induced by treatment with statins on monocyte tissue factor expression in hypercholesterolemic subjects 165
Time-dependent effect of statins on platelet function in hypercholesterolaemia 164
Variazioni diurne dell’ effetto anticoagulante dell’ eparina non frazionata in corso di infusione continua e.v. nell’ uomo. Modificazioni indotte da acido acetlsalicico per os 164
Structural and functional abnormality of systemic microvessels in cardiac syndrome X 163
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 161
Increased TNF-alpha production by peripheral blood mononuclear cells in patients with Krabbe's disease: effect of psychosine 160
In-hospital death and adverse clinical events in elderly patients according to disease clustering: the REPOSI study 159
Levosimendan improves pro/anti-inflammatory cytokines imbalance in male patients with advanced heart failure. A randomized, double-blind, placebo-controlled study 157
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study 157
Transmitral and pulmonary venous flow study in elite male runners and young adults 157
T cell activation and enhanced apoptosis in non-ST elevation myocardi infarction 156
Circulating esRAGE is Associated with a Pro-Inflammatory/Pro-Atherothrombotic Profile in Familial Combined Hyperlipidemia Patients with Non-alcoholic Fatty Liver Disease 155
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype 155
Statins discontinuation in compliant chronic users induces atherothrombotic profile despite baseline clinical setting and treatments 154
Evidences of new risk factors for retinal vein thrombosis 153
Genetics of the coenzyme Q10 pathway and rosuvastatin-induced muscle effects 152
Real-life experience of edoxaban treatment for venous thromboembolism (VTE)/pulmonary embolism (PE) in patients with isolated positive Lupus Anticoagulant (LAC) during the COVID-19 pandemic lockdown in Italy 151
Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes 151
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia 149
Role of genetic factors in statins side-effects 149
Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects 148
Safety of long-term simvastatin discontinuation 148
Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly 148
Genetic influence in statin intolerance 148
Systemic adenosine increase during cold pressor test is dependent on sympathetic activation 147
Role of platelets in tissue factor expression by monocytes in normal and hypercholesterolemic subjects. In vitro effect of cerivastatin 146
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series 145
Diatolic filling in hypertrophied hearts of elite runners: an echo-doppler study 143
Mechanism for antiplatelet action of statins 142
Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards 138
Early anti-thrombotic and anti-inflammatory actions of statins and fibrates -: time for adjuvant therapy in acute coronary syndromes? 138
Psoriasis successfully treated with guselkumab in a patient with systemic lupus erythematosus and acquired hemophilia A 138
Microvascular assessment in Behcet disease: videocapillaroscopic study. 136
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 131
Variazioni diurne dell'effetto anticoagulante in corso di infusione continua e.v. di eparina non frazionata nell'uomo.Modificazioni indotte da acido acetilsalicilico per os. 130
Effetto dell' acido acetilsalicilico e della pentossifillina sulle variazioni diurne dell' attività anticoagulante dell' eparina non frazionata somministrata per infusione continua endovenosa nell' uomo 130
Refractory Takayasu arteritis successfully treated with infliximab 124
Pro/anti-inflammatory cytokine imbalance in postischemic left ventricular remodeling 117
Relationship between serum complement and different lipid disorders 116
Report of two cases of subconjunctival haemorrhage as first sign of post‐pregnancy acquired haemophilia a (AHA) 114
Prospective Monitoring of Peripheral Blood CD26+ Leukemia Stem Cells in Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation 113
MEDICAL TREATMENT OF CRVO 113
Le sfide dell’integrazione in Toscana: una riflessione dall’Osservatorio sociale regionale 112
Hypercoagulable state in hypercholesterolemic subjects assessed by platelet-dependent thrombin generation. In vitro effect of cerivastatin 111
Peripheral Blood Flow-Cytometry Chronic Myeloid Leukemia Stem Cells Detection and Quantification during Tyrosine Kinase Inhibitors Therapy 101
Totale 18.190
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.641
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.022 0 0 0 0 0 176 76 229 196 124 138 83
2021/20221.328 104 162 94 161 70 22 63 36 59 128 122 307
2022/20231.842 112 147 274 234 172 373 33 156 186 30 97 28
2023/20241.531 57 36 123 74 53 464 501 34 16 39 41 93
2024/20252.848 66 142 286 146 372 142 52 147 233 114 336 812
2025/20264.751 529 993 1.018 801 1.363 47 0 0 0 0 0 0
Totale 18.916